
|Articles|January 12, 2009
Office of Inspector General Report
Office of Inspector General's report on the FDA's oversight of clinical investigators' financial information.
Advertisement
The U.S. Department of Health and Human Services' Office of Inspector General has published a report, "The Food and Drug Administration's Oversight of Clinical Investigators' Financial Information," which can be found at:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
3
Breaking Out of AI Pilot Mode in Clinical Development
4
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
5



